Vyjuvek

Vyjuvek (beremagene geperpavec) is a gene therapy gel for cutaneous use, designed to treat wounds. It delivers COL7A1 gene to promote collagen production in patients with dystrophic epidermolysis bullosa. Suitable for targeted wound healing applications.

Vyjuvek is used for what is known as gene therapy to treat chronic wounds, particularly in patients with dystrophic epidermolysis bullosa. It works by delivering a functional COL7A1 gene to the skin, supporting collagen production where it is lacking. This helps accelerate wound healing in affected areas.

Vyjuvek gel is applied directly to wounds, where it interacts with the skin to promote natural healing processes. Patients may notice gradual improvement in wound closure and reduced blistering over time. The gel is designed to integrate with the body’s own repair mechanisms.

Vyjuvek should only be handled and applied by trained healthcare professionals. Avoid contact with eyes, mucous membranes, or non-targeted skin areas. Store the gel at the recommended temperature and follow handling guidelines to maintain potency. Keep out of reach of children.

No specific drug interactions have been widely reported with Vyjuvek. However, it is important to inform your healthcare provider about all medications and treatments being used. Avoid using other topical treatments on the same wound area unless directed by a medical professional.